Savient Pharma (SVNT) and Radware (RDWR) Debut On Takeover Target List

September 15, 2010 5:29 PM EDT
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) and Radware Ltd. (Nasdaq: RDWR) have debuted on's "Top 50 Takeover Targets" list at M&A Central.

Savient Pharmaceuticals debuted at number 6, as the company has publicly disclosed it would seek a sale following approval of Krystexxa, which happened yesterday.

Radware Ltd (Nasdaq: RDWR) debuted at number 9, following reports from Globes that either HP (NYSE: HPQ) or IBM (NYSE: IBM) could be willing to pay as much as $1 billion for the company, or around $45/share.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog, Mergers and Acquisitions